Vincent Medical Holdings Income Statement

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	932.78	800.96	717.97	629.24	777.72
Revenue Growth (YoY)	16.46%	11.56%	14.10%	-19.09%	-32.69%
Cost of Revenue	605.34	540.97	477.59	463.89	518.62
Gross Profit	327.44	259.99	240.39	165.35	259.1
Selling, General & Admin	149.31	151.2	138	133.65	125.42
Research & Development	48.74	30.6	36.06	36.68	39.25
Other Operating Expenses	-4.62	-2.24	-0.64	-3.44	7.24
Operating Expenses	193.44	182.18	174.51	166.89	171.9
Operating Income	134.01	77.82	65.88	-1.54	87.2
Interest Expense	-0.9	-1.36	-1.68	-2.85	-2.43
Interest & Investment Income	1.3	1.2	0.7	0.51	0.38
Earnings From Equity Investments	0.84	-0.33	2.82	-1.66	-5.88
Currency Exchange Gain (Loss)	1.94	2.87	0.48	-5.77	0.81
EBT Excluding Unusual Items	137.2	80.2	68.2	-11.31	80.08
Gain (Loss) on Sale of Investments	-1	-1.15	-1.66	-3.82	-10.73
Gain (Loss) on Sale of Assets	-	-	0.45	0.62	-2.26
Asset Writedown	-6.56	-1.07	-0.08	-1.01	-0.92
Pretax Income	129.64	77.98	66.92	-15.52	66.18
Income Tax Expense	21.29	7.08	8.71	2.87	6.11
Earnings From Continuing Operations	108.35	70.9	58.21	-18.39	60.07
Minority Interest in Earnings	-3.97	-1.73	-0.93	0.99	0.63
Net Income	104.38	69.17	57.28	-17.4	60.7
Net Income to Common	104.38	69.17	57.28	-17.4	60.7
Net Income Growth	50.91%	20.76%	-	-	-72.01%
Shares Outstanding (Basic)	645	643	646	654	654
Shares Outstanding (Diluted)	645	643	646	654	661
Shares Change (YoY)	0.27%	-0.36%	-1.24%	-1.12%	1.49%
EPS (Basic)	0.16	0.11	0.09	-0.03	0.09
EPS (Diluted)	0.16	0.11	0.09	-0.03	0.09
EPS Growth	50.51%	21.20%	-	-	-72.42%
Free Cash Flow	-	-20.98	93.34	57.16	94.1
Free Cash Flow Per Share	-	-0.03	0.14	0.09	0.14
Dividend Per Share	0.050	0.033	0.028	-	0.045
Dividend Growth	51.52%	20.00%	-	-	-59.09%
Gross Margin	35.10%	32.46%	33.48%	26.28%	33.32%
Operating Margin	14.37%	9.71%	9.18%	-0.24%	11.21%
Profit Margin	11.19%	8.63%	7.98%	-2.77%	7.80%
Free Cash Flow Margin	-	-2.62%	13.00%	9.09%	12.10%
EBITDA	155.79	99.6	88.07	22.21	111.65
EBITDA Margin	16.70%	12.43%	12.27%	3.53%	14.36%
D&A For EBITDA	21.78	21.78	22.19	23.74	24.44
EBIT	134.01	77.82	65.88	-1.54	87.2
EBIT Margin	14.37%	9.71%	9.18%	-0.24%	11.21%
Effective Tax Rate	16.42%	9.08%	13.01%	-	9.23%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.